Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Seibert

Showing results (41-50 of 89) with videos related to

Pageof 9
Sort By:
Molecular Pharmacology|April 11, 1991
Monovalent cation and amiloride analog modulation of adrenergic ligand binding to the unglycosylated alpha 2B-adrenergic receptor subtypeA L Wilson, K Seibert, S Brandon, et al.
Cancer Research|October 4, 2000
The cyclooxygenase-2 inhibitor celecoxib is a potent preventive and therapeutic agent in the min mouse model of adenomatous polyposisR F Jacoby, K Seibert, C E Cole, et al.
Journal of the National Cancer Institute|October 1, 1983
Cytogenetic studies of human breast cancer lines: MCF-7 and derived variant sublinesJ Whang-Peng, E C Lee, C S Kao-Shan, et al.
Journal of Pharmaceutical Sciences|November 1, 1984
gamma-Aminobutyric acid uptake inhibition and anticonvulsant activity of nipecotic acid estersA M Crider, J D Wood, K D Tschappat, et al.
Advances in Prostaglandin, Thromboxane, and Leukotriene Research|January 1, 1987
PGD2 is transformed by human coronary arteries to 9 alpha, 11 beta-PGF2, which contracts human coronary artery ringsL J Roberts, K Seibert, T E Liston, et al.
Cancer Medicine|August 28, 2015
A role for the dehydrogenase DHRS7 (SDR34C1) in prostate cancerJulia K Seibert, Luca Quagliata, Cristina Quintavalle, et al.
The Biochemical Journal|April 24, 1999
Kinetic basis for selective inhibition of cyclo-oxygenasesJ K Gierse, C M Koboldt, M C Walker, et al.
Advances in Prostaglandin, Thromboxane, and Leukotriene Research|January 1, 1991
The biochemical and pharmacological manipulation of cellular cyclooxygenase (COX) activityK Seibert, J L Masferrer, J Y FU, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|August 1, 1995
A structural feature of N-[2-(cyclohexyloxy)-4-nitrophenyl] methanesulfonamide (NS-398) that governs its selectivity and affinity for cyclooxygenase 2 (COX2)R Huff, P Collins, S Kramer, et al.
The Journal of Clinical Investigation|May 1, 1994
Endogenous nitric oxide enhances prostaglandin production in a model of renal inflammationD Salvemini, K Seibert, J L Masferrer, et al.
Pageof 9

Showing results (41-50 of 89) with videos related to

Sort By:
Pageof 9
Molecular Pharmacology|April 11, 1991
Monovalent cation and amiloride analog modulation of adrenergic ligand binding to the unglycosylated alpha 2B-adrenergic receptor subtypeA L Wilson, K Seibert, S Brandon, et al.
Cancer Research|October 4, 2000
The cyclooxygenase-2 inhibitor celecoxib is a potent preventive and therapeutic agent in the min mouse model of adenomatous polyposisR F Jacoby, K Seibert, C E Cole, et al.
Journal of the National Cancer Institute|October 1, 1983
Cytogenetic studies of human breast cancer lines: MCF-7 and derived variant sublinesJ Whang-Peng, E C Lee, C S Kao-Shan, et al.
Journal of Pharmaceutical Sciences|November 1, 1984
gamma-Aminobutyric acid uptake inhibition and anticonvulsant activity of nipecotic acid estersA M Crider, J D Wood, K D Tschappat, et al.
Advances in Prostaglandin, Thromboxane, and Leukotriene Research|January 1, 1987
PGD2 is transformed by human coronary arteries to 9 alpha, 11 beta-PGF2, which contracts human coronary artery ringsL J Roberts, K Seibert, T E Liston, et al.
Cancer Medicine|August 28, 2015
A role for the dehydrogenase DHRS7 (SDR34C1) in prostate cancerJulia K Seibert, Luca Quagliata, Cristina Quintavalle, et al.
The Biochemical Journal|April 24, 1999
Kinetic basis for selective inhibition of cyclo-oxygenasesJ K Gierse, C M Koboldt, M C Walker, et al.
Advances in Prostaglandin, Thromboxane, and Leukotriene Research|January 1, 1991
The biochemical and pharmacological manipulation of cellular cyclooxygenase (COX) activityK Seibert, J L Masferrer, J Y FU, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|August 1, 1995
A structural feature of N-[2-(cyclohexyloxy)-4-nitrophenyl] methanesulfonamide (NS-398) that governs its selectivity and affinity for cyclooxygenase 2 (COX2)R Huff, P Collins, S Kramer, et al.
The Journal of Clinical Investigation|May 1, 1994
Endogenous nitric oxide enhances prostaglandin production in a model of renal inflammationD Salvemini, K Seibert, J L Masferrer, et al.
Pageof 9